Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 422.39% vs 0.00% in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is -84.62% vs -53.57% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is 23.50% vs -22.19% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 24.55% vs 5.12% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is 11.12% vs 10.05% in Mar 2024
Compare Balance Sheet Results of Anuh Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
25.06
5.89
19.17
325.47%
Share Warrants & Outstandings
Total Reserve
300.97
236.33
64.64
27.35%
Shareholder's Funds
326.02
242.22
83.80
34.60%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
2.14
-2.14
-100.00%
Secured Loans
0.00
2.14
-2.14
-100.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
-2.08
22.90
-24.98
-109.08%
Other Long Term Liabilities
0.06
1.66
-1.60
-96.39%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
2.03
0.67
1.36
202.99%
Total Non-Current Liabilities
0.01
27.01
-27.00
-99.96%
Current Liabilities
Trade Payables
156.84
5.05
151.79
3,005.74%
Other Current Liabilities
11.00
5.37
5.63
104.84%
Short Term Borrowings
10.50
0.36
10.14
2,816.67%
Short Term Provisions
0.17
0.30
-0.13
-43.33%
Total Current Liabilities
178.51
11.08
167.43
1,511.10%
Total Liabilities
504.55
280.31
224.24
80.00%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
111.06
7.53
103.53
1,374.90%
Less: Accumulated Depreciation
61.36
2.62
58.74
2,241.98%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
49.70
4.91
44.79
912.22%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.27
0.00
0.27
0.00%
Intangible assets under development
0.00
0.06
-0.06
-100.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
51.95
208.80
-156.85
-75.12%
Long Term Loans & Advances
2.64
10.53
-7.89
-74.93%
Other Non Current Assets
15.30
0.00
15.30
0.00%
Total Non-Current Assets
128.38
226.40
-98.02
-43.30%
Current Assets Loans & Advances
Current Investments
53.86
0.00
53.86
0.00%
Inventories
74.48
2.12
72.36
3,413.21%
Sundry Debtors
215.87
15.63
200.24
1,281.13%
Cash and Bank
19.74
4.37
15.37
351.72%
Other Current Assets
11.48
0.03
11.45
38,166.67%
Short Term Loans and Advances
0.75
31.76
-31.01
-97.64%
Total Current Assets
376.17
53.91
322.26
597.77%
Net Current Assets (Including Current Investments)
197.66
42.83
154.83
361.50%
Total Current Assets Excluding Current Investments
322.31
53.91
268.40
497.87%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
504.55
280.31
224.24
80.00%
Contingent Liabilities
25.26
0.00
25.26
0.00%
Total Debt
10.50
1.78
8.72
489.89%
Book Value per share (adjusted)
32.53
205.62
-173.09
-84.18%
Annual - Borrowings
Borrowings 10.50 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 422.39% vs 0.00% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.06 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -84.62% vs -53.57% in Mar 2024
Annual - Fixed Assets
Fixed Assets 49.97 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 23.50% vs -22.19% in Mar 2024
Annual - Investments
Investments 51.95 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 24.55% vs 5.12% in Mar 2024
Annual - Current Assets
Current Assets 376.17 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 11.12% vs 10.05% in Mar 2024
